Expert Interview
A Second View: Prescriber check in with gastroenterologists on their impression of Skyrizi in treating Ulcerative colitis
Ticker(s): ABBVInstitution: Mount Sinai Hospital
- Associate Professor in the Division of Gastroenterology and theDirector of the GI Microbial Therapeutics at the Icahn School of Medicine at Mount Sinai.
- Treats 30 patients wit C.diff.
- Developed the Fecal Microbiota Transplant (FMT) program to treat recurrentand refractory Clostridium difficile infection at Mount Sinai.
- research focuses on exploring the mechanismand clinical utility of FMT in Clostridioides difficile infection and Inflammatory BowelDisease.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
